Plain-English translation of NCT05669742 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing whether a medication called can help prevent or reduce weight gain and related metabolic problems (like high blood sugar and high blood pressure) that can happen when people with schizophrenia take . is an effective antipsychotic, but it can cause unwanted side effects. Researchers want to see if this medication can make safer and easier to tolerate.
While is very good at treating schizophrenia symptoms, many patients gain significant weight and develop metabolic problems like diabetes and high blood pressure. This trial exists to find a safe add-on treatment that could minimize these side effects and make antipsychotic treatment work better for patients overall.
You likely qualify if…
You likely don't qualify if…
Participants will be randomly assigned to take either the study medication or a placebo pill alongside their regular treatment. You would take your daily medication and attend visits where researchers will monitor your weight, blood sugar, blood pressure, and other metabolic markers to see if the treatment is helping. The study involves 40 people total and will be double-blind, meaning neither you nor the researchers will know which group you're in until the end.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Egypt